These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15072766)

  • 1. Immunotherapy for invasive fungal infections: from bench to bedside.
    Pappas PG
    Drug Resist Updat; 2004 Feb; 7(1):3-10. PubMed ID: 15072766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of efficacy trials of cytokines in combination with antifungal drugs.
    Kullberg BJ; Oude Lashof AM; Netea MG
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.
    Hamad M
    Scand J Immunol; 2008 Jun; 67(6):533-43. PubMed ID: 18397201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive immune therapy for fungal infections.
    Casadevall A; Pirofski LA
    Clin Infect Dis; 2001 Oct; 33(7):1048-56. PubMed ID: 11528579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections.
    Safdar A
    Clin Microbiol Infect; 2007 Jan; 13(1):1-4. PubMed ID: 17184281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.
    Anaissie EJ
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy against invasive mold infections.
    Antachopoulos C; Katragkou A; Roilides E
    Immunotherapy; 2012 Jan; 4(1):107-20. PubMed ID: 22150004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and fungal infections.
    Antachopoulos C; Roilides E
    Br J Haematol; 2005 Jun; 129(5):583-96. PubMed ID: 15916680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spanish Paediatric Infectious Diseases Society consensus document on the treatment of fungal infections based on the immune response].
    Martín A; Soler-Palacín P; Español T; Dapena JL; Urrutia E; Navarro M; Alvez F; Figueras C;
    An Pediatr (Barc); 2010 Dec; 73(6):362.e1-8. PubMed ID: 20638349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy against invasive fungal diseases in stem cell transplant recipients.
    Lehrnbecher T; Tramsen L; Koehl U; Schmidt S; Bochennek K; Klingebiel T
    Immunol Invest; 2011; 40(7-8):839-52. PubMed ID: 21627412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon- gamma therapy.
    Netea MG; Brouwer AE; Hoogendoorn EH; Van der Meer JW; Koolen M; Verweij PE; Kullberg BJ
    Clin Infect Dis; 2004 Nov; 39(9):e83-7. PubMed ID: 15494899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of immunoreconstitution in the management of refractory opportunistic fungal infections.
    Roilides E; Dignani MC; Anaissie EJ; Rex JH
    Med Mycol; 1998; 36 Suppl 1():12-25. PubMed ID: 9988488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficulties with fungal infections in acute myelogenous leukemia patients: immune enhancement strategies.
    Safdar A
    Oncologist; 2007; 12 Suppl 2():2-6. PubMed ID: 18039633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.
    Dignani MC; Rex JH; Chan KW; Dow G; deMagalhaes-Silverman M; Maddox A; Walsh T; Anaissie E
    Cancer; 2005 Jul; 104(1):199-204. PubMed ID: 15929126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for development of vaccines against fungal diseases.
    Dan JM; Levitz SM
    Drug Resist Updat; 2006 Jun; 9(3):105-10. PubMed ID: 16820318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of infections caused by rare filamentous fungi.
    Katragkou A; Roilides E
    Clin Microbiol Infect; 2012 Feb; 18(2):134-9. PubMed ID: 22044625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and mycoses.
    Stevens DA; Walsh TJ; Bistoni F; Cenci E; Clemons KV; Del Sero G; Fè d'Ostiani C; Kullberg BJ; Mencacci A; Roilides E; Romani L
    Med Mycol; 1998; 36 Suppl 1():174-82. PubMed ID: 9988506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
    Chamilos G; Kontoyiannis DP
    Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.